Comments on "considerations for an evidence-based definition of premature ejaculation in the DSM-V"

Journal of Sexual Medicine

Volumn 7, Issue 2 PART 1, 2010, Pages 679-689

  Morales, Alvaro ^a   Zargooshi, Javaad ^b   Jern, Patrick ^c   McCullough, Andrew ^d   Hellstrom, Wayne ^e   Shamloul, Rany ^f   Bella, Anthony J ^g   Becher, Edgardo F ^h   Rubio Aurioles, Eusebio ⁱ   Perelman, Michael A ^j   Palmer, Neil ^k   Rothman, Margaret ^l  

^a QUEEN S UNIVERSITY   (Canada)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ÅBO AKADEMI UNIVERSITY   (Finland)

^d NEW YORK UNIVERSITY   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CAIRO UNIVERSITY   (Egypt)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSIDAD DE BUENOS AIRES   (Argentina)

ⁱ A C AMSSAC Sexual Medicine Research   (Mexico)

^j WEILL CORNELL MEDICAL CENTER   (United States)

^k Keogh Institute for Medical Research   (Australia)

^l JOHNSON AND JOHNSON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR;

DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DISEASE SEVERITY; DISTRESS SYNDROME; EJACULATION DISORDER; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; HUMAN; MASTURBATION; NOTE; PENIS ERECTION; PRACTICE GUIDELINE; PREMATURE EJACULATION; PRIORITY JOURNAL; REFERENCE VALUE; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SYMPTOM;

EID: 75649146275     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01682_1.x     Document Type: Note

References (41)

1. Consensus development conference statement National Institutes of Health impotence. Int J Impot Res 1993, 5:181-99. National Institutes of Health
2. Morales A, Heaton JPW. Comments on medical therapy with emphasis on the treatment of hypogonadal states to the National Institutes of Health Consensus Development Conference Statement on Impotence. Int J Impot Res 1993, 5:253-354.
3. Salonia A, Saccá A, Briganti A, Del Carro U, Dehò F. Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: A case controlled study. J Sex Med 2009, 6:1755-62.
4. Sadeghi-Nejad H, Watson R. Premature ejaculation: Current medical treatment. J Sex Med 2008, 5:1037-50.
5. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and validation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-26.
6. Virag R, Frydman D, Legman M, Virag H. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology 1984, 35:79-87.
7. Morales A, Gingell C, Collins M, Vicker PA, Orterloh IH. Overall clinical safety of oral sildenafil citrate in the treatment of erectile dysfunction. Int J Impot Res 1998, 10:69-74.
8. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen RC, Rowland DL, Segraves R. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008, 5:1590-606.
9. Zargooshi J. Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran. J Sex Med 2009, 6:3478-89.
10. Waldinger MD, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: A contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med 2008, 5:1079-87.
11. Jern P, Santtila P, Johansson A, Varjonen M, Witting K, von der Pahlen B, Sandnabba NK. Subjectively measured ejaculation latency time and its association with different sexual activities while controlling for age and relationship length. J Sex Med 2009, 6:2658-78.
12. Waldinger M. Premature ejaculation: Definition and drug treatment. Drugs 2007, 67:547-68.
13. Jern P, Santtila P, Johansson A, Varjonen M, Witting K, Ålgars M, Alanko K, von der Pahlen B, Sandnabba NK. Indicators of premature ejaculation and their associations with sexual distress in a population-based sample of young twins and their siblings. J Sex Med 2008, 5:2191-201.
14. Waldinger M, Hengeveld M, Zwinderman A, Olivier S. An empirical operationalization study of DSM-IV criteria for premature ejaculation. Int J Psychiatry Clin Pract 1998, 2:287-93.
15. Hong LK. Survival of the fastest: On the origin of premature ejaculation. J Sex Res 1984, 20:109-22.
16. Gross SW. A practical treatise on impotence, sterility and allied disorders of the male sexual organs 1887, Philadelphia, Lea Brothers & Co
17. Eaton H. Clomipramine in the treatment of premature ejaculation. J Int Med Res 1973, 1:432-4.
18. Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, McNulty P, Rothman M, Jamieson C. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005, 2:358-67.
19. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip I, Adaikan PG, Becher E, Broderick GA, Buvat J. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. BJU Int 2008, 102:338-50.
20. Barada J, Lewis R, Wagner G. Should the condition of premature ejaculation be renamed? J Urol 2004, 171:881A.
21. Diagnostic and statistical manual of mental disorders DSM IV 1994, American Psychiatric Association, 4th, edition, Washington, DC, America Psychiatric Publishing
22. Diagnostic and statistical manual of mental disorders DSM IV TR 2000, American Psychiatric Association, 4th, edition, text revision, Washington, DC, America Psychiatric Publishing
23. Rosen RC, Althof S. Impact of premature ejaculation: The psychological quality of life, and sexual relationship consequences. J Sex Med 2008, 5:1296-307.
24. Althof SE. Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol 2006, 175:842-8. Pt 1
25. Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M. Development and validation of a premature ejaculation diagnostic tool. Eur Urol 2007, 52:565-73.
26. Arafa M, Shamloul R. Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). J Sex Med 2007, 4:1750-6.
27. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005, 2:492-7.
28. Giuliano F, Patrick DL, Porst H, La Pera G, Kokoszka A, Merchant S, Rothman M, Gagnon DD, Polverejan E. Premature ejaculation. Results from a five-country European observational study. Eur Urol 2008, 53:1048-57.
29. Patrick DL, Rowland D, Rothman M. Interrelationships among measures of premature ejaculation: The central role of perceived control. J Sex Med 2007, 4:780-8.
30. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. The majority of men with lifelong premature ejaculation prefer daily drug treatment: An observation study in a consecutive group of Dutch men. J Sex Med 2007, 4:1028-37.
31. Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998, 1:37-40.
32. Janssen PKC, Bakker SC, Réthelyi J, Zwinderman AH, Touw DJ, Olivier B, Waldinger MD. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med 2009, 6:276-84.
33. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994, 151:54-61.
34. Corty EW, Guardiani JM. Canadian and American sex therapists' perceptions of normal and abnormal ejaculatory latencies: How long should intercourse last? J Sex Med 2008, 5:1251-6.
35. Lann E. The use of drugs and technical aids to help experiencing orgasm in women. Presented at the XIX World Congress for Sexual Health 2009Goteborg Sweden, June 21, 2009
36. Patrick DL. Interrelationships among measures of premature ejaculation. The Central role of perceived control. J Sex Med 2007, 4:780-8.
37. Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control and distress associated with premature ejaculation. J Sex Med 2006, 3:465-75.
38. Brock GB, Bénard F, Casey R, Elliott SL, Gajewski JB, Lee JC. Canadian male sexual health council survey to assess prevalence and treatment of premature ejaculation in. Canada. J Sex Med 2009, 6:2115-23.
39. Rowland DL. Self reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004, 1:225-32.
40. Althof SE, Rowland DL. Identifying constructs and criteria for the diagnosis of premature ejaculation: Implication for making errors of classification. BJU Int 2008, 102:708-12.
41. Guiliano F, Patrick DL, Porst H. Premature ejaculation: Results from a five-country European observational study. J Sex Med 2005, 2:358-67.